JPH0649027A - インドール誘導体 - Google Patents

インドール誘導体

Info

Publication number
JPH0649027A
JPH0649027A JP5088844A JP8884493A JPH0649027A JP H0649027 A JPH0649027 A JP H0649027A JP 5088844 A JP5088844 A JP 5088844A JP 8884493 A JP8884493 A JP 8884493A JP H0649027 A JPH0649027 A JP H0649027A
Authority
JP
Japan
Prior art keywords
ester
compound according
formula
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5088844A
Other languages
English (en)
Japanese (ja)
Inventor
Alfredo Cugola
アルフレード、クーゴラ
Giovanni Gaviraghi
ジョバンニ、ガビラギ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo SpA filed Critical Glaxo SpA
Publication of JPH0649027A publication Critical patent/JPH0649027A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
JP5088844A 1992-04-16 1993-04-15 インドール誘導体 Pending JPH0649027A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9208492.0 1992-04-16
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
JPH0649027A true JPH0649027A (ja) 1994-02-22

Family

ID=10714220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5088844A Pending JPH0649027A (ja) 1992-04-16 1993-04-15 インドール誘導体
JP5517997A Pending JPH07505407A (ja) 1992-04-16 1993-04-15 インドール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP5517997A Pending JPH07505407A (ja) 1992-04-16 1993-04-15 インドール誘導体

Country Status (41)

Country Link
US (4) US5374649A (2)
EP (1) EP0568136A1 (2)
JP (2) JPH0649027A (2)
KR (1) KR100264114B1 (2)
CN (1) CN1042331C (2)
AP (1) AP480A (2)
AT (1) AT403917B (2)
AU (1) AU666927B2 (2)
BE (1) BE1006343A5 (2)
BG (1) BG62136B1 (2)
BR (1) BR1100323A (2)
CA (3) CA2094076A1 (2)
CH (1) CH685630A5 (2)
CY (1) CY2038B1 (2)
CZ (1) CZ285799B6 (2)
DK (1) DK169890B1 (2)
ES (1) ES2105924B1 (2)
FI (1) FI106198B (2)
FR (1) FR2690919B1 (2)
GB (2) GB9208492D0 (2)
GE (1) GEP19991704B (2)
GR (1) GR1001619B (2)
HK (1) HK95797A (2)
HU (2) HU217964B (2)
IL (1) IL105412A (2)
IS (1) IS3994A (2)
IT (1) IT1265325B1 (2)
LU (1) LU88248A1 (2)
MX (1) MX9302195A (2)
MY (1) MY112232A (2)
NO (1) NO301879B1 (2)
NZ (1) NZ247413A (2)
OA (1) OA10103A (2)
PL (1) PL176451B1 (2)
RO (1) RO113242B1 (2)
RU (1) RU2129544C1 (2)
SE (1) SE504336C2 (2)
SK (1) SK281941B6 (2)
TW (1) TW224457B (2)
WO (1) WO1993021153A1 (2)
ZA (1) ZA932642B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010104093A1 (ja) 2009-03-10 2010-09-16 参天製薬株式会社 ４，６－ジクロロ－１ｈ－インドール－２－カルボン酸誘導体又はその塩を有効成分として含有する視神経障害の予防又は治療剤

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
JP3334805B2 (ja) * 1993-05-27 2002-10-15 メレルファーマスーティカルズ インコーポレイテッド ３−（インドール−３−イル）−プロペン酸誘導体類及びその製剤組成物
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (2) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
US6030968A (en) * 1996-09-17 2000-02-29 The Regents Of The University Of California Positive AMPA receptor modulation to enhance brain neurotrophic factor expression
JP2001501221A (ja) * 1996-09-30 2001-01-30 ヘキスト・マリオン・ルセル・インコーポレイテツド Ｎｍｄａ（ｎ―メチル―ｄ―アスパラギン酸）アンタゴニスト
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
CA2416706C (en) * 2000-07-31 2009-04-07 Dainippon Pharmaceutical Co., Ltd. Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
MXPA04005427A (es) * 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
CA2528065A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
RU2247563C1 (ru) * 2003-06-16 2005-03-10 Пятигорская государственная фармацевтическая академия Способ получения твердой лекарственной формы, содержащей глюкозамина гидрохлорид
ATE473967T1 (de) * 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
JP2007517056A (ja) * 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールｄａａｏ阻害剤
RU2281755C2 (ru) * 2004-04-19 2006-08-20 Пятигорская государственная фармацевтическая академия Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для ректального применения
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP2455075B1 (en) 2005-07-06 2018-06-20 Sunovion Pharmaceuticals Inc. Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
NZ569608A (en) 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
CN101421228B (zh) 2006-03-31 2014-05-21 塞普拉柯公司 手性酰胺和胺的制备
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CA2676432A1 (en) 2007-01-18 2008-07-24 Sepracor, Inc. Inhibitors of d-amino acid oxidase
CA2688493C (en) 2007-05-31 2016-04-19 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
US20090247644A1 (en) * 2008-03-28 2009-10-01 Forest Laboratories Holdings Limited Memantine formulations
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN106687626B (zh) 2014-04-30 2021-01-26 宇凤·简·曾 作为d-氨基酸氧化酶抑制剂的已知化合物的用途
EP3512840B1 (en) 2016-09-14 2024-03-06 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
DE69118539T2 (de) * 1990-07-16 1996-09-19 Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio Exzitatorische Aminosäureantagonisten
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010104093A1 (ja) 2009-03-10 2010-09-16 参天製薬株式会社 ４，６－ジクロロ－１ｈ－インドール－２－カルボン酸誘導体又はその塩を有効成分として含有する視神経障害の予防又は治療剤

Also Published As

Publication number Publication date
FI944800L (fi) 1994-10-12
AU3692393A (en) 1993-10-21
DK43193D0 (da) 1993-04-15
US5373018A (en) 1994-12-13
MY112232A (en) 2001-05-31
IL105412A (en) 1998-02-22
CA2094075A1 (en) 1993-10-17
FR2690919B1 (fr) 1995-05-05
BG99111A (bg) 1995-05-31
ES2105924B1 (es) 1998-07-01
CN1042331C (zh) 1999-03-03
BG62136B1 (bg) 1999-03-31
NO943913L (no) 1994-12-14
OA10103A (en) 1996-12-18
JPH07505407A (ja) 1995-06-15
SK124194A3 (en) 1995-05-10
RO113242B1 (ro) 1998-05-29
IS3994A (is) 1993-10-17
NO943913D0 (no) 1994-10-14
ATA75293A (de) 1997-11-15
US5510367A (en) 1996-04-23
US5374648A (en) 1994-12-20
FR2690919A1 (fr) 1993-11-12
CZ285799B6 (cs) 1999-11-17
NO301879B1 (no) 1997-12-22
GB2266091B (en) 1995-08-09
ZA932642B (en) 1994-01-10
KR100264114B1 (ko) 2000-11-01
AP480A (en) 1996-03-22
CA2094076A1 (en) 1993-10-17
IL105412A0 (en) 1993-08-18
WO1993021153A1 (en) 1993-10-28
CN1085212A (zh) 1994-04-13
TW224457B (2) 1994-06-01
PL176451B1 (pl) 1999-05-31
GR1001619B (el) 1994-07-29
DK43193A (da) 1993-10-17
ITRM930236A0 (it) 1993-04-15
GEP19991704B (en) 1999-08-05
SE9301241D0 (sv) 1993-04-15
AT403917B (de) 1998-06-25
FI944800A0 (fi) 1994-10-12
SE9301241L (sv) 1993-10-17
AP9300524A0 (en) 1993-04-30
DK169890B1 (da) 1995-03-27
GB9208492D0 (en) 1992-06-03
SE504336C2 (sv) 1997-01-13
HU9402975D0 (en) 1995-02-28
IT1265325B1 (it) 1996-10-31
EP0568136A1 (en) 1993-11-03
RU2129544C1 (ru) 1999-04-27
HUT70526A (en) 1995-10-30
MX9302195A (es) 1994-03-31
CH685630A5 (fr) 1995-08-31
CA2094073A1 (en) 1993-10-17
ITRM930236A1 (it) 1994-10-15
FI106198B (fi) 2000-12-15
GB2266091A (en) 1993-10-20
SK281941B6 (sk) 2001-09-11
LU88248A1 (fr) 1994-03-01
HU211826A9 (en) 1995-12-28
ES2105924A1 (es) 1997-10-16
US5374649A (en) 1994-12-20
RU94045915A (ru) 1996-09-10
HK95797A (en) 1997-08-08
BR1100323A (pt) 2000-06-27
HU217964B (hu) 2000-05-28
BE1006343A5 (fr) 1994-07-26
GB9307808D0 (en) 1993-06-02
AU666927B2 (en) 1996-02-29
CY2038B1 (en) 1998-04-30
NZ247413A (en) 1995-12-21
CZ254394A3 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
JPH0649027A (ja) インドール誘導体
US5686461A (en) Indole derivatives
AP877A (en) Tetrahydroquinoline derivatives as EAA antagonists.
JPH09503770A (ja) Ｎｍｄａアンタゴニストとしてのインドール誘導体
US5977136A (en) Tetrahydroquinolines as NMDA antagonists
KR19980702735A (ko) Ｅａａ 길항제로서의 인돌 유도체
US6028080A (en) Quinolin-2-(1H)-ones
KR20010005567A (ko) 퀴놀린-2-카르복실산 유도체 및 그의 흥분성 아미노산 길항제로서의 용도
WO1995007887A1 (en) Indole derivatives as antagonists of excitatory amino acids